Summary

catsupsun0 Users

  • Early on Adjustments to DCE-MRI Biomarkers May possibly Predict Survival Results in Patients using Innovative Hepatocellular Carcinoma soon after Sorafenib Malfunction: A pair of Possible Phase 2 Trials.
Offline Offline
Posts:
0 (0 per day)
Age:
N/A
Date Registered:
2025-07-14, 14:42:12
Local Time:
2025-07-16, 19:41:44
Last Active:
2025-07-14, 19:48:52
Signature:
© 2020 by JSLS, Journal of the Society of Laparoscopic & Robotic Surgeons.Background and Objectives The aim of this retrospective monocentric